CVB
CURVEBEAM FPO [CVB]
Healthcare · ASX Small Cap
$0.0530 +0.0%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical38
Catalyst52
Sentiment50
Fundamental47
Momentum49
Risk Gate42
Get alerts when CVB's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Drifting lower — down 3.6% over the last 5 days
- Lagging the Small Ords index — relative strength of 0.86, underperforming its peers
- Critical cash runway (1.6 quarters)
- Low P/S ratio (2.1x)
- Near 52-week low (1% of range)
- Small-cap ($20-100M)
- CANSLIM I: Institutional ownership (21%)
- Sentiment is mixed — no strong consensus either way
- The bigger volume days are the up days — volume-weighted momentum is positive (1.45%/day)
- Altman Z-Score distress zone (0.26 < 1.81, low-confidence approx)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (2/9, low-confidence approx)
- Deeply negative margins (-133%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about CVB
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Initial Director's Interest Notice - Patrick Fisher
NONE Notification regarding unquoted securities - CVB
NONE Independent Non-Executive Director Appointment
LOW CVB to Present at NWR Healthcare Conference
Recent ASX Announcements
| 2026-03-24 | Initial Director's Interest Notice - Patrick Fisher |
| 2026-03-19 | CVB to Present at NWR Healthcare Conference |
| 2026-03-18 | Notification regarding unquoted securities - CVB |
| 2026-03-18 | Independent Non-Executive Director Appointment |
| 2026-02-26 | Commentary to App 4D - Dec 2025 Half Year PRICE SENSITIVE |
Key Metrics
$25.3M
Market Cap
376K
Avg Volume
1.2x
Vol Ratio
$0.05 — $0.17
52-Week Range
0.2%
Short Interest
N/A
Cash Runway
-41.8%
ROE
-133.1%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 80% |
| L | Leader vs Laggard | laggard | RS: -6 |
| I | Institutional Sponsorship | pass | Inst: 21% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #26 of 117 · Sector avg: 46
View all Healthcare signals →Track CVB and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required